VA tests cheaper hearing aids for veterans, with strings attached

What it does

This bill directs the VA to run a two-year pilot program testing whether over-the-counter hearing aids (FDA-cleared devices) work as well as prescription hearing aids for veterans with mild-to-moderate hearing loss, and whether covering them would be cost-effective. The VA will enroll eligible veterans at two or more facilities, compare OTC aids to professionally fitted prescription aids, measure outcomes, and report findings to Congress. A separate Government Accountability Office study will examine hearing aid coverage gaps for all Americans with mild-to-moderate hearing loss and recommend policy changes.

Why we flagged it

The bill establishes a time-limited demonstration project to evaluate a specific healthcare intervention (OTC hearing aid coverage) for a defined population (VA-enrolled veterans), with mandatory reporting and a parallel GAO study. It is a straightforward pilot, not a permanent entitlement or deregulation.

What the text implies

• If the pilot shows OTC aids are cost-effective, the VA may face pressure to expand coverage permanently, potentially shifting hearing aid procurement away from traditional audiologist-fitted models and affecting VA audiology staffing and training.
• The requirement for mobile phone/data access may exclude some rural or lower-income veterans, creating a digital divide within the eligible population despite the bill's stated goal of serving diverse populations.
• The GAO study's scope (all Americans with mild-to-moderate hearing loss) may generate recommendations for broader Medicare/Medicaid coverage changes, extending the bill's policy influence beyond the VA.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Veterans gain access to a potentially lower-cost hearing aid option through a rigorous evaluation, with no restrictions on existing benefits. The pilot is designed to expand choice and affordability while maintaining clinical oversight. The GAO study broadens the inquiry to all Americans, supporting evidence-based policy.

Who stands to gain

• Over-the-counter hearing aid manufacturers (FDA-cleared device makers)
• Telehealth/mobile app developers supporting OTC hearing aid functionality

Named in the bill

Department of Veterans Affairs, Food and Drug Administration, Government Accountability Office, Senate Committee on Veterans' Affairs, House Committee on Veterans' Affairs, Veterans Integrated Services Networks

Where it stands

3 cosponsors: 2 Republicans, 1 Democrats.

• Jan 29, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Jan 29, 2026 — Referred to Senate Committee on Veterans' Affairs · Congress.gov: “Read twice and referred to the Committee on Veterans' Affairs”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $1,400,000 in lobbying spend. A filing names 13 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Marsha Blackburn, the sponsor, reported $133,620 in PAC receipts in the 2026 cycle.

• Consumer Technology Association — $1,370,000 on 1 filing
• International Hearing Society — $30,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.